We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Inverness Medical Acquires Benelux Distributor Orange Medical

By Labmedica staff writers
Posted on 15 May 2007
Inverness Medical Innovations, Inc. (Waltham, MA, USA), a manufacturer and marketer of rapid diagnostic products for the consumer and professional markets, has acquired Benelux distributor Orange Medical (Tilburg, The Netherlands) in an all cash deal for approximately €4.2 million, or US$5.7 million.

The acquisition of Orange Medical, which has companies in the Netherlands and Belgium, will increase Inverness' direct distribution network for its professional diagnostic products into Benelux. The acquisition is consistent with Inverness' efforts to continue to improve margins by bringing distribution in-house.

Inverness Medical Innovations is a developer of advanced diagnostic devices and is presently exploring new opportunities for its proprietary electrochemical and other technologies in a variety of professional diagnostic and consumer-oriented applications including immuno-diagnostics with a focus on women's health, cardiology, and infectious disease.

Orange Medical is an independent company active the Benelux (Belgium, Netherlands, Luxemburg) and serving hospitals and laboratories in the health care sector. Its selling and marketing activities are focused in the following market segments: immunodiagnostics, reproduction, and fertility prenatal diagnostics point-of-care (POC).


Related Links:
Inverness Medical Innovations
Orange medical

New
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Anti-Secukinumab ELISA
LISA-TRACKER anti-Secukinumab
New
Vibrio Cholerae O1/O139 Rapid Test
StrongStep Vibrio Cholerae O1/O139 Antigen Combo Rapid Test

Latest Industry News

Bio-Techne and ALZpath Partner to Advance Neurodegenerative Disease Research and Treatment

Microbiologics Acquires Diagnostic Quality Controls Manufacturer SensID

Beckman Coulter Partners with BioPorto for Global Distribution of Acute Kidney Injury NGAL Tests